Medsolve Dynamics

From 20 years on the vendor side of LINAC capital and service negotiations, the data point most radiation oncology programs do not see with the same precision the vendor sees it: their own unbooked machine hours. Every unbooked hour is a fixed cost paid for and not recovered. The 15-minute utilization audit is the cheapest margin discipline in the 2026 reimbursement environment. medsolvedynamics.c...

Capital decisions hold up when the year-five reality is considered before the signature. They break when only year-one numbers are. From 20 years on the vendor side and now on the program side, the year-five question that protects margin through a multi-year operating commitment in radiation oncology. medsolvedynamics.com | team@medsolvedynamics.com

From 20 years on the vendor side and now on the program side, the math that wins capital approval is not the math the program runs in year two. The reimbursement environment moved more than the headline rate change. medsolvedynamics.com | team@medsolvedynamics.com

Benign disease radiation uses LINAC capacity that is already paid for in most programs. The growth question is referral pathway, not capital. From 20 years of watching programs add and grow service lines. medsolvedynamics.com | team@medsolvedynamics.com

From 20 years on the vendor side and now on the program side, the capital form decision that gets skipped on most theranostics service-line additions. Build or partner sets the next decade. With reference to Kenneth Brooks and Christine Stone’s published build case study at Wellstar Health System. medsolvedynamics.com | team@medsolvedynamics.com

Capital decisions in radiation oncology are not point-in-time decisions. The proforma that wins approval at signature is not the proforma that runs the program in year five. From 20 years on the vendor side and now on the program side, the math that protects margin through a full capital cycle. medsolvedynamics.com | team@medsolvedynamics.com

A moment from the AMAC Spring Symposium 2026 talk on the day I told a room of oncology administrators that I have watched programs lose margin on contracts I helped sell them. Plus the 17-year ROI case study. medsolvedynamics.com | team@medsolvedynamics.com

A short clip from the AMAC Spring Symposium 2026 talk on the discipline programs need to apply to every capital decision in the current environment. Forward-looking, not policy-blame. medsolvedynamics.com | team@medsolvedynamics.com

The capital case in a vendor proforma is usually solid. The operating case is rarely modeled. From 20 years on the vendor side selling these programs, here is the operational reality that shows up in year two and never lives in the original proforma. Applies to LINAC purchases, theranostics expansions, and benign disease program builds. medsolvedynamics.com | team@medsolvedynamics.com

Jeff Siupik, 35 years in oncology operations, on where volume responsibility actually belongs in a healthy program. The C-suite looks at P&L. The clinical team looks at compassionate care. Where leaders most often misallocate the volume expectation, and where it should sit instead. Full episode: https://youtu.be/9bPM8rjsv6Y medsolvedynamics.com | team@medsolvedynamics.com #RadiationOncology #O...

Yoel Bakas sits down with Jeff Siupik, a healthcare executive with 35 years in oncology operations and 25 years in oncology leadership. Jeff has put in eight to ten linear accelerators across his career, led oncology programs through every reimbursement shift since the early 1990s, and currently oversees operations across a multi-program system. The conversation walks through the actual job of an...

Hiring and retention decisions are landing on the same desks as AI tool decisions, often in the same week. After 20 years on the vendor side, here is the discipline most programs are missing: the same questions you would ask of any capital line, applied to the people on the team and the tools being sold to replace them. medsolvedynamics.com | team@medsolvedynamics.com #RadiationOncology #OncologyL...

From the Medsolve Dynamics conversation with Heather Turner, radiation oncology operator with 14 years from therapist to director. The contracts are not the problem. The autopilot is. medsolvedynamics.com | team@medsolvedynamics.com #RadiationOncology #ServiceContracts #VendorNegotiation #OncologyLeadership

The economic case for a LINAC purchase rarely fails at signature. It fails in years two through eight, when the bundled add-ons start collecting service contracts and software renewals. After 20 years on the vendor side, here is what the inside of that conversation looks like, and why bundles are designed exactly this way. medsolvedynamics.com | team@medsolvedynamics.com #RadiationOncology #LINAC...

Most oncology capital and service negotiations are decided before anyone sits down. Vendor teams map your budget range, rehearse responses to your objections, and identify pricing flexibility they never surface unless you ask the right way. Yoel Bakas spent 20+ years on the vendor side of those conversations at Varian, GE HealthCare, ViewRay, and Mevion before founding Medsolve Dynamics. In this s...

After 20 years on the vendor side of oncology at GE HealthCare, ViewRay, and Varian, Yoel Bakas launched Medsolve Dynamics to work from your program side. In this episode, he walks through what Medsolve actually does: capital strategy on LINAC and theranostics purchases, service contract renegotiation before escalator clauses compound, financial case building for theranostics and benign disease se...

Most oncology service contracts renew automatically unless a specific window is used to renegotiate. Yoel Bakas, founder of Medsolve Dynamics, walks through the specific mechanics of a renewal clock that most program administrators miss until it has already closed — and what a single overlooked provision on page 7 cost one cancer program. Twenty years on the vendor side of oncology means knowing w...

The conversation highlights the pitfalls of AI procurement, the consequences of procurement failure, misleading claims in AI sales, and key questions for procurement. It emphasizes the importance of considering adoption requirements and the impact on workflow when purchasing AI solutions. Takeaways Procurement failure Adoption requirements medsolvedynamics.com team@medsolvedynamics.com

The conversation explores the critical question of whether decisions hold up at 80% of the current reimbursement, emphasizing the importance of considering this in every capital decision and service renewal. Takeaways Financial decisions must consider sustainability at 80% reimbursement Every purchase decision should be evaluated based on sustainability at 80% reimbursement medsolvedynamics.com te...

A physicist's excitement about a new tool without a clear problem to solve. Takeaways Tool adoption without a clear problem The allure of new technology medsolvedynamics.com team@medsolvedynamics.com

Preparation and Anticipation in Negotiations Takeaways Preparation is key Anticipate objections medsolvedynamics.com team@medsolvedynamics.com

The conversation explores the impact of contracts on margins and highlights the importance of paying attention to contract details, especially key provisions that can have a significant financial impact. Takeaways Contract provisions can have significant financial impact Importance of paying attention to contract details medsolvedynamics.com team@medsolvedynamics.com

The conversation emphasizes the importance of answering key questions before requesting a quote from a vendor, highlighting the vendor's influence on unanswered questions and the significance of defining the problem before pricing. It also mentions an upcoming presentation at the AMAC® Spring Symposium. Takeaways Answer key questions before engaging with vendors Defining the problem before pricing...

Heather Turner has 14 years of experience in radiation oncology. Radiation therapist, operations manager for a new cancer center build, director. In this conversation she and Yoel Bakas talk about the real challenges programs are navigating in 2026. Staffing shortages across therapists, dosimetrists, physicists, and physicians. Workflow breakdowns between radiation oncology, medical oncology, and...

In the context of radiation oncology capital conversations, the focus on price often overshadows other critical factors such as service coverage, software license terms, training, and delivery timelines. Vendors have already modeled the price negotiation and have a floor in mind, leading to a conversation that stays within their designed model. Takeaways Price conversation overshadows critical fac...